Please Note: This trial is no longer enrolling new participants
Phase I/II Trial of Lurbinectedin with Osimertinib in Transformed Small Cell Lung Cancer
| Protocol No. | CTO-IUSCCC-0891 | Scope | National |
|---|---|---|---|
| Principal Investigator | Misty Shields | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I/II |
